HUP0002333A2 - Trombózis ellen hatásos oligoszacharidkeverék - Google Patents
Trombózis ellen hatásos oligoszacharidkeverékInfo
- Publication number
- HUP0002333A2 HUP0002333A2 HU0002333A HUP0002333A HUP0002333A2 HU P0002333 A2 HUP0002333 A2 HU P0002333A2 HU 0002333 A HU0002333 A HU 0002333A HU P0002333 A HUP0002333 A HU P0002333A HU P0002333 A2 HUP0002333 A2 HU P0002333A2
- Authority
- HU
- Hungary
- Prior art keywords
- mixture
- weight
- nac
- gal
- percent
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 230000002785 anti-thrombosis Effects 0.000 title abstract 2
- 229920001542 oligosaccharide Polymers 0.000 title abstract 2
- 150000002482 oligosaccharides Chemical class 0.000 title abstract 2
- 150000002016 disaccharides Chemical group 0.000 abstract 3
- 229920000045 Dermatan sulfate Polymers 0.000 abstract 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 abstract 1
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 abstract 1
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- IAJILQKETJEXLJ-SKNVOMKLSA-N aldehydo-L-iduronic acid Chemical class O=C[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O IAJILQKETJEXLJ-SKNVOMKLSA-N 0.000 abstract 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 abstract 1
- 239000004019 antithrombin Substances 0.000 abstract 1
- 150000007942 carboxylates Chemical class 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 abstract 1
- 229940051593 dermatan sulfate Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000008273 hexosamines Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Abstract
A találmány tárgya dermatán-szulfátból előállított, lineárisoligoszacharidok keveréke, amely kis mennyiségben az N-acetil-D-galaktózamintól (Gal-Nac) eltérő D-glükuronsavból és hexózaminokbólszármazó maradékokat tartalmazhat; amely keverék különböző számbanismétlődő L-iduronsavból (IdoA) és Gal-Nac-ból származó, (1) általánosképletű szulfatált diszacharid-egységeket tartalmaz, ahol R jelentéseH vagy SO3-; és n értéke a keverék legalább 90 százalékában a 3-37tartományban van, amely keverék jellemzői az alábbiak: (a)molekulatömegük a keveréknek legalább 90 százalékára vonatkozóan az1600 és 20 000 közötti tartományban van, (b) kéntartalmuk 6,0-8,0tömegszázalék, (c) a szulfátnak a karboxiláthoz viszonyított aránya1,2-1,6, (d) diszulfatált diszacharidtartalmuk a monoszulfatáltdiszacharidtartalom 20-60 tömegszázaléka és (e) antitrombin-aktivitásuk 20-60 NE/mg. A találmány szerinti keverék trombózis ellenihatóanyagként alkalmazható. Ó
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9711443.3A GB9711443D0 (en) | 1997-06-03 | 1997-06-03 | Chemical suppositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0002333A2 true HUP0002333A2 (hu) | 2000-12-28 |
| HUP0002333A3 HUP0002333A3 (en) | 2002-01-28 |
Family
ID=10813494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0002333A HUP0002333A3 (en) | 1997-06-03 | 1998-05-15 | Oligosaccharide mixtures having antithrombotic activity |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6486137B1 (hu) |
| EP (1) | EP0986580B1 (hu) |
| JP (1) | JP2002502454A (hu) |
| KR (1) | KR20010013284A (hu) |
| CN (1) | CN1145643C (hu) |
| AT (1) | ATE236933T1 (hu) |
| AU (1) | AU740671B2 (hu) |
| CA (1) | CA2293587A1 (hu) |
| CZ (1) | CZ292622B6 (hu) |
| DE (1) | DE69813216T2 (hu) |
| DK (1) | DK0986580T3 (hu) |
| ES (1) | ES2193534T3 (hu) |
| GB (1) | GB9711443D0 (hu) |
| HK (1) | HK1028251A1 (hu) |
| HU (1) | HUP0002333A3 (hu) |
| NZ (1) | NZ501254A (hu) |
| PL (1) | PL337231A1 (hu) |
| PT (1) | PT986580E (hu) |
| RU (1) | RU2216548C2 (hu) |
| WO (1) | WO1998055514A1 (hu) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6440445B1 (en) | 1996-09-30 | 2002-08-27 | Brigham & Women's Hospital | Methods and compounds for treatment of abnormal uterine bleeding |
| WO2003018032A1 (en) * | 2001-08-28 | 2003-03-06 | Leo Pharma A/S | Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate |
| US20040171819A1 (en) | 2002-10-10 | 2004-09-02 | Aventis Pharma S.A. | Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
| CN100345868C (zh) * | 2003-04-18 | 2007-10-31 | 山东大学 | 一种低分子硫酸皮肤素及其制备方法 |
| US20070219161A1 (en) * | 2004-03-26 | 2007-09-20 | Junichi Tamura | Preparation Process Of Oligoglycosaminoglycan, And Reducing End Glucuronic Acid Type Oligochondroitin Sulfate And Pharmaceutical Composition Comprising The Same |
| US20050261241A1 (en) * | 2004-05-19 | 2005-11-24 | Celsus Biopharmaceuticals, Inc. | Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses |
| SG191613A1 (en) * | 2008-05-30 | 2013-07-31 | Momenta Pharmaceuticals Inc | Saccharide structures and methods of making and using such structures |
| ES2364683B1 (es) * | 2009-12-29 | 2012-08-08 | Bioibérica S.A. | Disacáridos sulfatados para el tratamiento de enfermedades neurodegenerativas y/o neurovasculares. |
| WO2013006906A1 (en) * | 2011-07-11 | 2013-01-17 | Commonwealth Scientific And Industrial Research Organisation | Dermatan sulphate, pharmaceutical compositions and process for producing same |
| WO2013095215A1 (en) | 2011-12-19 | 2013-06-27 | Dilaforette Ab | Low anticoagulant heparins |
| ME02994B (me) | 2011-12-19 | 2018-10-20 | Dilafor Ab | Glikozaminoglikani koji nisu anтikoagulanтi koji sadrže ponavljajuću jedinicu disaharida i njihova medicinska upotreba |
| CN103160486A (zh) * | 2013-04-02 | 2013-06-19 | 黑龙江迪龙制药有限公司 | 一种猪凝血酶的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1230582B (it) * | 1988-10-21 | 1991-10-28 | Opocrin S P A Lab Farmabiologi | Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica |
| IT1251183B (it) * | 1991-08-28 | 1995-05-04 | Opocrin Spa | Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono. |
| IT1251182B (it) * | 1991-08-28 | 1995-05-04 | Opocrin Spa | Oligosaccaridi di dermatan solfato, processo per la loro produzione e relative composizioni farmaceutiche. |
| US5922690A (en) * | 1996-04-25 | 1999-07-13 | Van Gorp; Cornelius L. | Dermatan disulfate, an inhibitor of thrombin generation and activation |
-
1997
- 1997-06-03 GB GBGB9711443.3A patent/GB9711443D0/en active Pending
-
1998
- 1998-05-15 DE DE69813216T patent/DE69813216T2/de not_active Revoked
- 1998-05-15 EP EP98929355A patent/EP0986580B1/en not_active Revoked
- 1998-05-15 AT AT98929355T patent/ATE236933T1/de not_active IP Right Cessation
- 1998-05-15 US US09/445,146 patent/US6486137B1/en not_active Expired - Fee Related
- 1998-05-15 DK DK98929355T patent/DK0986580T3/da active
- 1998-05-15 WO PCT/EP1998/003007 patent/WO1998055514A1/en not_active Application Discontinuation
- 1998-05-15 CZ CZ19994316A patent/CZ292622B6/cs not_active IP Right Cessation
- 1998-05-15 HU HU0002333A patent/HUP0002333A3/hu unknown
- 1998-05-15 NZ NZ501254A patent/NZ501254A/en unknown
- 1998-05-15 PT PT98929355T patent/PT986580E/pt unknown
- 1998-05-15 CN CNB988057972A patent/CN1145643C/zh not_active Expired - Fee Related
- 1998-05-15 AU AU79146/98A patent/AU740671B2/en not_active Ceased
- 1998-05-15 JP JP50140299A patent/JP2002502454A/ja not_active Ceased
- 1998-05-15 PL PL98337231A patent/PL337231A1/xx unknown
- 1998-05-15 KR KR19997011277A patent/KR20010013284A/ko active IP Right Grant
- 1998-05-15 CA CA002293587A patent/CA2293587A1/en not_active Abandoned
- 1998-05-15 RU RU2000100374/04A patent/RU2216548C2/ru not_active IP Right Cessation
- 1998-05-15 ES ES98929355T patent/ES2193534T3/es not_active Expired - Lifetime
-
2000
- 2000-11-10 HK HK00107173A patent/HK1028251A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0986580B1 (en) | 2003-04-09 |
| NZ501254A (en) | 2001-12-21 |
| CZ431699A3 (cs) | 2000-04-12 |
| PT986580E (pt) | 2003-08-29 |
| ATE236933T1 (de) | 2003-04-15 |
| DK0986580T3 (da) | 2003-08-04 |
| PL337231A1 (en) | 2000-08-14 |
| DE69813216T2 (de) | 2004-01-29 |
| CN1145643C (zh) | 2004-04-14 |
| WO1998055514A1 (en) | 1998-12-10 |
| ES2193534T3 (es) | 2003-11-01 |
| AU7914698A (en) | 1998-12-21 |
| GB9711443D0 (en) | 1997-07-30 |
| JP2002502454A (ja) | 2002-01-22 |
| KR20010013284A (ko) | 2001-02-26 |
| RU2216548C2 (ru) | 2003-11-20 |
| DE69813216D1 (de) | 2003-05-15 |
| HK1028251A1 (en) | 2001-02-09 |
| US6486137B1 (en) | 2002-11-26 |
| EP0986580A1 (en) | 2000-03-22 |
| AU740671B2 (en) | 2001-11-08 |
| CZ292622B6 (cs) | 2003-11-12 |
| CN1259143A (zh) | 2000-07-05 |
| HUP0002333A3 (en) | 2002-01-28 |
| CA2293587A1 (en) | 1998-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0002333A2 (hu) | Trombózis ellen hatásos oligoszacharidkeverék | |
| US4791195A (en) | Novel oligosaccharides having pharmacological properties by depolymerization of heparin | |
| ITMI942240A1 (it) | Polisaccaridi aventi un elevato contenuto di acido iduronico | |
| JP2009538386A5 (hu) | ||
| CY1112808T1 (el) | Μειγματα ολιγοσακχαριτων προερχομενων απο την ηπαρινη, η παρασκευη τους και φαρμακευτικες συνθεσεις που τα περιεχουν | |
| DE68921633T2 (de) | Oligosaccharide mit antiatherosclerotischer wirkung. | |
| KR900018129A (ko) | 콘드로이틴 황산염, 데르마탄황산염 및 히알루론산의 술포아미노 유도체와 그 약제학적 성질 | |
| HUP0401693A2 (hu) | Részlegesen deszulfatált glükóz-amino-glükánok származékai mint a herparanáz enzim inhibitorai, előállításuk és alkalmazásuk, valamint ilyen származékokat tartalmazó gyógyszerkészítmények | |
| SI2794667T1 (en) | Low anticoagulant heparins | |
| TW580391B (en) | Sulfated oligosaccharides having anticoagulant/antithrombotic activity | |
| Mulloy et al. | Assignment of the 1H-nmr spectra of heparin and heparan sulphate | |
| Cifonelli et al. | Structural characteristics of heparan sulfates with varying sulfate contents | |
| GR3024582T3 (en) | Semi-synthetic glycosaminoglycans containing alpha-L-galacturonic acid substituted with nucleophilic radicals in position 3 | |
| Kindness et al. | Enhancement of antithrombin III activity by carrageenans | |
| RU2000100374A (ru) | Смеси олигосахаридов, обладающие антитромботической активностью | |
| Scott et al. | Detection of secondary structure in glycosaminoglycans via the1H nmr signal of the acetamido NH group | |
| AU2396392A (en) | Oligosaccharides of dermatan sulphate, process for their production, and associated pharmaceutical compositions | |
| JP2002145779A5 (hu) | ||
| Conrad et al. | Structural analysis of periodate-oxidized heparin | |
| PT95511A (pt) | Processo de producao de glicosaminoglicuronano sulfato e de composicoes farmaceuticas | |
| IL165807A (en) | Process for preparing epimerized derivatives of k5 polysaccharide with a very high degree of sulfation and new epi k5-n,o-sulfated polysaccharide derivatives thus obtained | |
| Scully et al. | Heparan sulphate with no affinity for antithrombin III and the control of haemostasis | |
| IL171981A (en) | Glycosaminoglycans for treatment of emotional dysfunctions | |
| Fransson et al. | Glycosaminoglycan—lipoprotein interactions: 2. Structure of heparin-releted variants with high affinity for low density lipoprotein | |
| Ishihara | Dermatan Sulfate Another Potent Mediator of FGF-2 in Wound Healing |